Latest kidney cancer news

23 Mar 2023
Savolitinib and durvalumab for metastatic papillary kidney cancer

23 Mar 2023
One Cancer Voice petition: 80,000 demand diagnosis and treatment is top priority

20 Mar 2023
Adjuvant nivolumab plus ipilimumab for localised kidney cancer

20 Mar 2023
Fat loss may result in worse outcomes for patients treated with immunotherapy for metastatic kidney cancer

16 Mar 2023
Results from a phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of kidney cancer

16 Mar 2023
Improved health-related quality of life using a mindfulness app for kidney cancer patients

16 Mar 2023
How time of day of immunotherapy infusion affects kidney cancer outcomes

15 Mar 2023
Benefits persist for lenvatinib plus pembrolizumab in advanced kidney cancer

9 Mar 2023
TKI treatment breaks may not affect outcomes in kidney cancer

7 Mar 2023
ASCO GU 20023: Cabozantinib as a second-line treatment for patients with advanced kidney cancer

7 Mar 2023
ASCO GU 2023: A triple combination for previously untreated kidney cancer patients

6 Mar 2023